Paper Details
- Home
- Paper Details
Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients.
Author: HartikainenJ, JantunenE, NousiainenT, PuustinenJ, RantalaA, RemesJ, VanninenE, VuolteenahoO
Original Abstract of the Article :
Idarubicin has been shown to have similar or superior antileukemic activity to daunorubicin with less cumulative cardiotoxicity. However, data of acute cardiovascular effects of idarubicin are scanty but may have clinical significance in predicting late cardiovascular complications. In the present s...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1111/j.1600-0609.1998.tb01099.x
データ提供：米国国立医学図書館（NLM）
Idarubicin: A Double-Edged Sword in the Desert of Leukemia Treatment
The fight against leukemia is a grueling journey through a vast and unpredictable desert, with researchers constantly searching for effective weapons to combat this devastating disease. This study delves into the acute cardiovascular effects of idarubicin, a potent chemotherapy drug used in treating leukemia. It's like navigating a treacherous path through a desert landscape, carefully analyzing the potential risks and benefits of this powerful weapon. This study explores the acute neurohumoral and cardiovascular effects of idarubicin, a chemotherapy drug used in treating leukemia. It's like investigating the impact of a powerful storm on the desert environment, seeking to understand the potential consequences of this powerful drug.
The study reveals that idarubicin can cause acute neurohumoral activation and subclinical myocardial dysfunction, highlighting the need for careful monitoring and management of cardiovascular risks in patients undergoing idarubicin treatment. This discovery is like finding a hidden oasis in the desert, offering a chance to avert a potentially fatal outcome.
Idarubicin: A Double-Edged Sword in the Desert of Leukemia Treatment
This study highlights the potential cardiovascular risks associated with idarubicin treatment, emphasizing the need for careful monitoring and management in patients undergoing this therapy. It's like finding a hidden oasis in the desert, offering a chance to avert a potentially fatal outcome.
Navigating the Desert of Leukemia Treatment: Understanding the Risks and Benefits of Idarubicin
This study emphasizes the importance of a careful and comprehensive approach to leukemia treatment, acknowledging the potential risks and benefits of powerful chemotherapy drugs like idarubicin. It's like a guide through a complex and challenging desert landscape, offering insights into the intricacies of leukemia treatment and the importance of managing potential side effects.
Dr. Camel's Conclusion
This study provides valuable insights into the acute cardiovascular effects of idarubicin, highlighting the need for careful monitoring and management of cardiovascular risks in patients undergoing this therapy. It's like finding a hidden oasis in the desert, offering a chance to avert a potentially fatal outcome.
Date :
- Date Completed 1999-01-04
- Date Revised 2019-09-09
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.